Clinical and pathological implications of miRNA in bladder cancer
Cornelia Braicu,1 Roxana Cojocneanu-Petric,1,2 Sergiu Chira,1 Anamaria Truta,1,3 Alexandru Floares,4 Bogdan Petrut,5,6 Patriciu Achimas-Cadariu,7,8,* Ioana Berindan-Neagoe1,9–11,*1Research Center for Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu&a...
Guardado en:
Autores principales: | Braicu C, Cojocneanu-Petric R, Chira S, Truta A, Floares A, Petrut B, Achimas-Cadariu P, Berindan-Neagoe I |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/09c895f4e9f74217804070b75de66363 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects
por: Berindan-Neagoe I, et al.
Publicado: (2012) -
Identification of the circRNA-miRNA-mRNA Regulatory Network in Bladder Cancer by Bioinformatics Analysis
por: Jiancheng Lv, et al.
Publicado: (2021) -
Distinctive serum miRNA profile in mouse models of striated muscular pathologies.
por: Nicolas Vignier, et al.
Publicado: (2013) -
Urinary miRNA profiles discriminate between obstruction-induced bladder dysfunction and healthy controls
por: Michelle von Siebenthal, et al.
Publicado: (2021) -
Impact of host genes and strand selection on miRNA and miRNA* expression.
por: Marta Biasiolo, et al.
Publicado: (2011)